معرفی
Professor Pleasantine Mill is a leading researcher at the University of Edinburgh, serving as Group Leader within the MRC Human Genetics Unit at the Institute of Genetics and Cancer. She received her BSc in Microbiology and Immunology from McGill University and completed her PhD in Medical and Molecular Genetics at the University of Toronto, where she studied Gli transcription factors in Hedgehog signaling using mouse models.
Her research focuses on the genetics of cilia biology, investigating how defects in these specialized cellular structures lead to developmental disorders and postnatal health issues collectively known as ciliopathies. Professor Mill employs a multidisciplinary approach combining genetic screens, human disease genetics, advanced imaging techniques, and therapeutic genome editing to address fundamental questions about cilia assembly, function, and potential treatments for ciliopathies.
Professor Mill's publication record demonstrates consistent high-impact research, with recent papers in Science (2024), eLife (2021), and Developmental Cell (2018). Her work spans multiple subfields including ciliary microtubule dynamics, dynein assembly mechanisms, cilia-cell cycle relationships, and therapeutic applications of genome editing for ciliopathies. The research shows an evolving trajectory from basic cilia genetics toward translational applications and advanced imaging approaches.
Scientific recognition:
- Canadian NSERC Post-doctoral Fellowship
- Caledonian Research Fellowship
- Multiple major research grants including MRC, European Commission, and LifeArc funding
- Extensive media coverage of her research including The Times, The Sun, and international outlets
Professor Mill actively supervises PhD students and postdoctoral researchers, with current projects spanning precision medicine, macular research, and AI-integrated cilia studies. Her lab maintains strong clinical collaborations and participates in national networks focused on rare diseases. The research group benefits from substantial funding through multiple active projects with the Medical Research Council, European Commission, and other major funders, enabling cutting-edge research in cilia biology and its implications for human health.
The Mill Lab focuses on four interconnected research strands: genetic screens to dissect ciliary complexity, human disease genetics to identify ciliopathy alleles, advanced imaging techniques to visualize dynamic ciliary structures, and therapeutic genome editing approaches to potentially correct ciliopathies. This integrated approach positions the lab at the forefront of cilia research with significant potential for clinical translation.
